Low body weight and body mass index may be associated with musculoskeletal pain following imatinib discontinuation in chronic myeloid leukemia.

Leuk Res Rep · 2017 · PMC5402624 · PMID 28462083

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

[2] In a previous imatinib suspension and validation (ISAV) study, analysis of the quality of life showed a trend towards increased pain score following the cessation of IM [3] .

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.